McLaughlin Laura
School of Nursing, Saint Louis University, MO, USA.
Oncol Nurs Forum. 2013 Jan;40(1):E4-13. doi: 10.1188/13.ONF.E4-E13.
PURPOSE/OBJECTIVES: To describe the prevalence of issues with taste function in survivors of head and neck cancer.
Exploratory, cross-sectional.
Outpatients from Saint Louis University Cancer Center in Missouri.
92 adult head and neck cancer survivors, heterogeneous in cancer site, treatment type, and time post-treatment, ranging from three months to more than 28 years after completion of therapy.
Taste discrimination was assessed using high, medium, and low concentrations of sweet, salty, sour, and bitter tasting solutions.
Taste, percentage of weight change, tumor site and stage, treatment type, and time since completion of therapy.
Eighty-five of 92 participants had some measurable taste dysfunction. Confusion between bitter and sour and the inability to discriminate among the different concentrations of the sweet solutions were common. Statistically significant weight loss was associated with dysgeusia.
Taste dysfunction was a persistent problem across all categories of head and neck cancer treatments, sites, and stages. Participants who reported the loss of one or more specific taste modality performed poorly on the taste test. However, participants could not accurately predict which taste was most severely impaired.
Taste dysfunction is a long-term treatment-related side effect for head and neck cancer survivors. Assessing for taste changes and dysgeusia are important nursing considerations, as taste loss is distressing and associated with decreased appetite. Future studies are needed to identify interventions to help patients better manage and adapt to this long-term complication of cancer therapy.
Flavors are recognized by taste, texture, aroma, thermal quality, and visual cues. A disruption of one or more of those sensory experiences alters flavor recognition. Having intact taste sense but impaired flavor recognition is possible. Finally, taste is not accurately self-reported because it is commonly confused with flavor recognition.
目的/目标:描述头颈癌幸存者味觉功能问题的发生率。
探索性横断面研究。
密苏里州圣路易斯大学癌症中心的门诊患者。
92名成年头颈癌幸存者,癌症部位、治疗类型和治疗后时间各不相同,治疗结束后3个月至28年以上。
使用高、中、低浓度的甜、咸、酸、苦味觉溶液评估味觉辨别能力。
味觉、体重变化百分比、肿瘤部位和分期、治疗类型以及治疗结束后的时间。
92名参与者中有85人存在某种可测量的味觉功能障碍。苦与酸之间的混淆以及无法区分不同浓度的甜味溶液很常见。味觉障碍与统计学上显著的体重减轻有关。
味觉功能障碍是所有头颈癌治疗类别、部位和分期中持续存在的问题。报告失去一种或多种特定味觉模式的参与者在味觉测试中表现不佳。然而,参与者无法准确预测哪种味觉受损最严重。
味觉功能障碍是头颈癌幸存者与治疗相关的长期副作用。评估味觉变化和味觉障碍是重要的护理考量因素,因为味觉丧失令人痛苦且与食欲下降有关。需要进一步研究以确定干预措施,帮助患者更好地管理和适应这种癌症治疗的长期并发症。
味道是通过味觉、质地、香气、热感和视觉线索来识别的。这些感官体验中的一种或多种受到干扰会改变味道识别。有可能味觉完好但味道识别受损。最后,味觉通常与味道识别混淆,因此无法准确自我报告。